Wu CL - Search Results

1

Assessing prostate cancer growth with mRNA of spermine metabolic enzymes.

Kaul D, Wu CL, Adkins CB, Jordan KW, Defeo EM, Habbel P, Peterson RT, McDougal WS, Pohl U, Cheng LL. Kaul D, et al. Among authors: wu cl. Cancer Biol Ther. 2010 May 1;9(9):736-42. doi: 10.4161/cbt.9.9.11549. Epub 2010 May 18. Cancer Biol Ther. 2010. PMID: 20215859 Free article.

2

Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T.

Cheng LL, Wu C, Smith MR, Gonzalez RG. Cheng LL, et al. FEBS Lett. 2001 Apr 6;494(1-2):112-6. doi: 10.1016/s0014-5793(01)02329-8. FEBS Lett. 2001. PMID: 11297745 Free article.

3

High-resolution magic angle spinning proton NMR analysis of human prostate tissue with slow spinning rates.

Taylor JL, Wu CL, Cory D, Gonzalez RG, Bielecki A, Cheng LL. Taylor JL, et al. Among authors: wu cl. Magn Reson Med. 2003 Sep;50(3):627-32. doi: 10.1002/mrm.10562. Magn Reson Med. 2003. PMID: 12939772 Free article.

4

Proton high-resolution magic angle spinning NMR analysis of fresh and previously frozen tissue of human prostate.

Wu CL, Taylor JL, He W, Zepeda AG, Halpern EF, Bielecki A, Gonzalez RG, Cheng LL. Wu CL, et al. Magn Reson Med. 2003 Dec;50(6):1307-11. doi: 10.1002/mrm.10645. Magn Reson Med. 2003. PMID: 14648580 Free article.

5

Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.

Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, Tretiakova MS, Young RH, Weiss LM, Blute RD Jr, Brendler CB, Krausz T, Xu JC, Rock KL, Amin MB, Yang XJ. Jiang Z, et al. Among authors: wu cl. Histopathology. 2004 Sep;45(3):218-25. doi: 10.1111/j.1365-2559.2004.01930.x. Histopathology. 2004. PMID: 15330799

6

Quantitative pathology in tissue MR spectroscopy based human prostate metabolomics.

Burns MA, He W, Wu CL, Cheng LL. Burns MA, et al. Among authors: wu cl. Technol Cancer Res Treat. 2004 Dec;3(6):591-8. doi: 10.1177/153303460400300609. Technol Cancer Res Treat. 2004. PMID: 15560717 Free article.

7

Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy.

Cheng LL, Burns MA, Taylor JL, He W, Halpern EF, McDougal WS, Wu CL. Cheng LL, et al. Among authors: wu cl. Cancer Res. 2005 Apr 15;65(8):3030-4. doi: 10.1158/0008-5472.CAN-04-4106. Cancer Res. 2005. PMID: 15833828

8

Reduction of spinning sidebands in proton NMR of human prostate tissue with slow high-resolution magic angle spinning.

Burns MA, Taylor JL, Wu CL, Zepeda AG, Bielecki A, Cory D, Cheng LL. Burns MA, et al. Among authors: wu cl. Magn Reson Med. 2005 Jul;54(1):34-42. doi: 10.1002/mrm.20523. Magn Reson Med. 2005. PMID: 15968646 Free article.

9

Aberrant splicing of cables gene, a CDK regulator, in human cancers.

Zhang H, Duan HO, Kirley SD, Zukerberg LR, Wu CL. Zhang H, et al. Among authors: wu cl. Cancer Biol Ther. 2005 Nov;4(11):1211-5. doi: 10.4161/cbt.4.11.2085. Epub 2005 Nov 8. Cancer Biol Ther. 2005. PMID: 16177568 Free article.

10

Pathologic outcome of laparoscopic and open radical prostatectomy.

Dahl DM, He W, Lazarus R, McDougal WS, Wu CL. Dahl DM, et al. Among authors: wu cl. Urology. 2006 Dec;68(6):1253-6. doi: 10.1016/j.urology.2006.08.1054. Epub 2006 Dec 4. Urology. 2006. PMID: 17141845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,970 results

Search Page

Filters